REGN vs. VHT

Last updated Jun 3, 2026

REGN (Regeneron Pharmaceuticals, Inc.) is a stock, while VHT (Vanguard Health Care ETF) is Health & Biotech Equities fund tracking the MSCI US Investable Market Health Care 25/50 Index. Over the past 10 years, REGN returned 4.25%/yr vs 9.17%/yr for VHT. A 0.55 correlation means they provide meaningful diversification when combined.

Performance

REGN vs. VHT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regeneron Pharmaceuticals, Inc. (REGN) and Vanguard Health Care ETF (VHT). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, REGN achieves a -21.68% return, which is significantly lower than VHT's -4.81% return. Over the past 10 years, REGN has underperformed VHT with an annualized return of 4.25%, while VHT has yielded a comparatively higher 9.17% annualized return.

REGN

• 1D: 0.38%
• 1M: -13.91%
• YTD: -21.68%
• 6M: -18.52%
• 1Y: 23.51%
• 3Y*: -6.34%
• 5Y*: 3.75%
• 10Y*: 4.25%

VHT

• 1D: -1.21%
• 1M: 0.62%
• YTD: -4.81%
• 6M: -4.41%
• 1Y: 13.73%
• 3Y*: 5.85%
• 5Y*: 4.42%
• 10Y*: 9.17%

*Multi-year figures are annualized to reflect compound growth (CAGR)

REGN vs. VHT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
REGN Regeneron Pharmaceuticals, Inc.	-21.68%	8.96%	-18.90%	21.73%	14.25%	30.72%	28.66%	0.53%	-0.65%	2.42%
VHT Vanguard Health Care ETF	-4.81%	15.46%	2.66%	2.52%	-5.60%	20.57%	18.29%	21.87%	5.58%	23.26%

Correlation

The correlation between REGN and VHT is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.56
Correlation (3Y) Calculated over the trailing 3-year period	0.58
Correlation (5Y) Calculated over the trailing 5-year period	0.58
Correlation (10Y) Calculated over the trailing 10-year period	0.57
Correlation (All Time) Calculated using the full available price history since Feb 2, 2004	0.55

The correlation between REGN and VHT has been stable across timeframes, ranging from 0.55 to 0.58 - a consistent structural relationship.

Return for Risk

REGN vs. VHT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

REGN

REGN Risk / Return Rank: 61
REGN Sharpe Ratio Rank: 63
REGN Sortino Ratio Rank: 58
REGN Omega Ratio Rank: 57
REGN Calmar Ratio Rank: 60
REGN Martin Ratio Rank: 68

VHT

VHT Risk / Return Rank: 27
VHT Sharpe Ratio Rank: 27
VHT Sortino Ratio Rank: 28
VHT Omega Ratio Rank: 25
VHT Calmar Ratio Rank: 28
VHT Martin Ratio Rank: 25

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

REGN vs. VHT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and Vanguard Health Care ETF (VHT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	REGN	VHT	Difference
Sharpe ratio Return per unit of total volatility	0.72	0.96	-0.24
Sortino ratio Return per unit of downside risk	1.23	1.51	-0.28
Omega ratio Gain probability vs. loss probability	1.15	1.17	-0.02
Calmar ratio Return relative to maximum drawdown	0.91	1.34	-0.43
Martin ratio Return relative to average drawdown	3.30	3.39	-0.09
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

REGN vs. VHT - Sharpe Ratio Comparison

The current REGN Sharpe Ratio is 0.72, which is comparable to the VHT Sharpe Ratio of 0.96. The chart below compares the historical Sharpe Ratios of REGN and VHT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	REGN	VHT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.72	0.96	-0.24
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.12	0.30	-0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.13	0.54	-0.41
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.56	-0.40

Drawdowns

REGN vs. VHT - Drawdown Comparison

The maximum REGN drawdown since its inception was -91.81%, which is greater than VHT's maximum drawdown of -39.12%. Use the drawdown chart below to compare losses from any high point for REGN and VHT.

Drawdown Indicators

	REGN	VHT	Difference
Max Drawdown Largest peak-to-trough decline	-91.81%	-39.12%	-52.69%
Max Drawdown (1Y) Largest decline over 1 year	-25.85%	-10.40%	-15.45%
Max Drawdown (3Y) Largest decline over 3 years	-59.69%	-16.91%	-42.78%
Max Drawdown (5Y) Largest decline over 5 years	-59.69%	-17.71%	-41.98%
Max Drawdown (10Y) Largest decline over 10 years	-59.69%	-28.85%	-30.84%
Current Drawdown Current decline from peak	-49.42%	-7.83%	-41.59%
Average Drawdown Average peak-to-trough decline	-42.38%	-5.99%	-36.39%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.16%	4.12%	+3.04%

Volatility

REGN vs. VHT - Volatility Comparison

Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 12.02% compared to Vanguard Health Care ETF (VHT) at 4.00%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than VHT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	REGN	VHT	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.02%	4.00%	+8.02%
Volatility (6M) Calculated over the trailing 6-month period	22.49%	10.14%	+12.35%
Volatility (1Y) Calculated over the trailing 1-year period	32.72%	14.32%	+18.40%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	30.75%	14.96%	+15.79%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.16%	16.94%	+15.22%

Dividends

REGN vs. VHT - Dividend Comparison

REGN's dividend yield for the trailing twelve months is around 0.60%, less than VHT's 1.72% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
REGN Regeneron Pharmaceuticals, Inc.	0.60%	0.46%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VHT Vanguard Health Care ETF	1.72%	1.61%	1.53%	1.36%	1.33%	1.14%	1.21%	1.89%	1.38%	1.31%	1.45%	1.22%

Frequently Asked Questions

Can I hold both REGN and VHT in my portfolio?

REGN and VHT have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, REGN or VHT?

REGN has higher volatility (12.02%) compared to VHT (4.00%). In terms of maximum drawdown, REGN dropped -91.81% vs VHT's -39.12%.

Which has better risk-adjusted returns?

VHT currently has the higher Sharpe Ratio (0.96 vs 0.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.